Year-Round, Routine Testing of Multiple Body Site Specimens for Human Parechovirus in Young Febrile Infants.

Authors:
Tomatis Souverbielle C; Wang H; Feister J; Campbell J; Medoro A and 6 more

Journal:
J Pediatr

Publication Year: 2020

DOI:
10.1016/j.jpeds.2020.10.004

PMCID:
PMC7546655

PMID:
33045237

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Pediatr

Abbreviation: J Pediatr

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pediatrics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Cardiac Magnetic Resonance Findings of Coronavirus Disease 2019 (COVID-19) Vaccine-Associated Myope…
Dove ML; Slesnick TC; Oster ME and 3 more (2023) - Transparency Score: 3/6
The Impact of COVID-19 on Infant Maltreatment Emergency Department and Inpatient Medical Encounters.
Rebbe R; Reddy J; Kuelbs CL and 2 more (2023) - Transparency Score: 3/6
Comorbidities Associated with Hospitalization and Progression Among Adolescents with Symptomatic Co…
Campbell JI; Dubois MM; Savage TJ and 6 more (2022) - Transparency Score: 3/6
Effect of Outreach Messages on Adolescent Well-Child Visits and Coronavirus Disease 2019 Vaccine Ra…
Burkhardt MC; Berset AE; Xu Y and 2 more (2022) - Transparency Score: 4/6
Health Surveillance in a Down Syndrome Specialty Clinic: Implementation of Electronic Health Record…
Santoro SL; Howe YJ; Krell K and 2 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"A Mejias has received research grants from NIH/NIAID (grant AI112524) and Janssen. AM has also received fees for participation in advisory boards from Janssen, Sanofi, Roche and Merck. OR has received research grants from Janssen, NIH, and the Bill & Melinda and Gates Foundation; fees from Merck, Sanofi/Medimmune, and Pfizer for participation in advisory boards; and fees from Pfizer for educational lectures. AL has received research grants from Diasorin, Qiagen and BioFire Diagnostics and participates in Advisory boards for BioFiore Diagnostics, Qiagen and Medscape. These conflicts were not related to the current study."

Evidence found in paper:

"A Mejias has received research grants from NIH/NIAID (grant AI112524) and Janssen. AM has also received fees for participation in advisory boards from Janssen, Sanofi, Roche and Merck. OR has received research grants from Janssen, NIH, and the Bill & Melinda and Gates Foundation; fees from Merck, Sanofi/Medimmune, and Pfizer for participation in advisory boards; and fees from Pfizer for educational lectures. AL has received research grants from Diasorin, Qiagen and BioFire Diagnostics and participates in Advisory boards for BioFiore Diagnostics, Qiagen and Medscape. These conflicts were not related to the current study."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025